This article in Corporate Disputes highlights a recent roundtable discussion featuring Group Vice President and Life Sciences Practice Leader Greg Bell and his thoughts on trends in intellectual property and the impact of high-profile IP infringement cases on the life sciences landscape more broadly.
Looking ahead to 2026: Trends and expectations for International Arbitration
Across both investor-state and commercial cases, quantum debates have recently turned on attribution under concurrent shocks, the interaction of contract terms...